IDEAYA Biosciences, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
IDEAYA Biosciences, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2019 to Q3 2024.
  • IDEAYA Biosciences, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $15.1M, a 148% increase year-over-year.
  • IDEAYA Biosciences, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $46.6M, a 196% increase year-over-year.
  • IDEAYA Biosciences, Inc. annual Nonoperating Income (Expense) for 2023 was $21.5M, a 458% increase from 2022.
  • IDEAYA Biosciences, Inc. annual Nonoperating Income (Expense) for 2022 was $3.85M, a 660% increase from 2021.
  • IDEAYA Biosciences, Inc. annual Nonoperating Income (Expense) for 2021 was $506K, a 40.4% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $46.6M $15.1M +$8.99M +148% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $37.6M $12.2M +$7.37M +154% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $30.3M $11.4M +$8.81M +334% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $21.5M $7.96M +$5.72M +255% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q3 2023 $15.8M $6.09M +$5.13M +537% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $10.6M $4.78M +$4.34M +980% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $6.28M $2.64M +$2.43M +1175% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $3.85M $2.24M +$2.09M +1328% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q3 2022 $1.76M $955K +$824K +629% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $938K $443K +$339K +326% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $599K $207K +$93K +81.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $506K $157K +$12K +8.28% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q3 2021 $494K $131K +$61K +87.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $433K $104K -$95K -47.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $528K $114K -$321K -73.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $849K $145K -$393K -73% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-07
Q3 2020 $1.24M $70K -$584K -89.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $1.83M $199K -$380K -65.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $2.21M $435K -$90K -17.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $2.3M $538K Oct 1, 2019 Dec 31, 2019 10-K 2022-03-18
Q3 2019 $654K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $579K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $525K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.